• Sell-side advice to CROS NT on its sale to Alira Health

Sell-side advice to CROS NT on its sale to Alira Health

Deal TypeM&A
IndustryLife Sciences

BDO has provided sell-side advice to CROS NT on its sale to Alira Health, a PE backed international healthcare and life sciences advisory services firm headquartered in the United States.

CROS NT is a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT specialises in biometric services and supports clients with a full-service clinical offering delivered through a network of trusted partners.

CROS NT’s global biometrics capabilities will bring additional expertise to Alira Health. The synergies among Alira Health’s Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s ability to serve clients across their solutions lifecycle. In addition, CROS NT will also enable Alira Health to expand their direct clinical operations in Europe.

We enjoyed working with the team at BDO who provided insightful professional advice and support. The team’s collaborative approach and availability were very valuable in the process, as was their detailed knowledge of the Life Sciences sector. I would thoroughly recommend anybody considering using the BDO team to do so.”

Giorgio Jones, CFO, CROS NT